Phylodynamics of HIV-1 from a Phase-III AIDS Vaccine Trial in North America

In 2003, a phase III placebo-controlled trial (VAX004) of a candidate HIV-1 vaccine (AIDSVAX B/B) was completed in 5,403 volunteers at high risk for HIV-1 infection from North America and the Netherlands. A total of 368 individuals became infected with HIV-1 during the trial. The envelope glycoprote...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Losada, Marcos, Jobes, David V., Sinangil, Faruk, Crandall, Keith A., Posada, David, Berman, Phillip W.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806245/
https://www.ncbi.nlm.nih.gov/pubmed/19864468
http://dx.doi.org/10.1093/molbev/msp254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806245/
https://www.ncbi.nlm.nih.gov/pubmed/19864468
http://dx.doi.org/10.1093/molbev/msp254

Ejemplares similares